The Patent Finder

Neuvana, LLC

22 patents currently held · Updated Nov 15, 2026
8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jun 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 24, 2027
    The maintenance fee for Norepinephrine Compositions and Methods Therefor (US 10,420,735) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
  • 1 fee due May 12, 2027
    The maintenance fee for Norepinephrine Compositions and Methods Therefor (US 10,471,026) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
  • 2 fees due Aug 25, 2027
  • 1 fee due Sep 10, 2027
    The maintenance fee for Atropine Pharmaceutical Compositions (US 10,583,132) comes due Sep 10, 2027. Unpaid by Mar 10, 2028, it lapses early.
  • 1 fee due Oct 7, 2027
    The maintenance fee for Atropine Pharmaceutical Compositions (US 10,610,525) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.
  • 1 fee due Nov 12, 2027
    The maintenance fee for Norepinephrine Compositions and Methods Therefor (US 10,646,458) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,782,584Transcutaneous electrostimulator and methods for electric stimulation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,130,809Transcutaneous electrostimulator and methods for electric stimulation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,989,773Multi-Channel Wide Field Imaging System and Optical System for Use Therein
In force
 · High confidence
In forceHigh confidence
US 10,159,657Norepinephrine Compositions and Methods Therefor
In force
 · Medium confidence
In forceMedium confidence
US 10,226,436Norepinephrine Compositions and Methods Therefor
In force
 · Medium confidence
In forceMedium confidence
US 10,420,735Norepinephrine Compositions and Methods Therefor
In force
 · Medium confidence
In forceMedium confidence
US 10,471,026Norepinephrine Compositions and Methods Therefor
In force
 · High confidence
In forceHigh confidence
US 10,568,850Norepinephrine Compositions and Methods Therefor
In force
 · Medium confidence
In forceMedium confidence
US 10,646,458Norepinephrine Compositions and Methods Therefor
In force
 · High confidence
In forceHigh confidence
US 10,251,875Atropine Pharmaceutical Compositions
In force
 · High confidence
In forceHigh confidence
10 of 22 patents shown.
Pro members see all 22.
Pro members: see all 22 patents
Also on record, not counted in the 22: 8 patents in force now held by others · 3 lapsed for an unpaid fee · 30 ended at full term · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 1 abandoned · 3 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited